ROS1
Basic information
Region (hg38): 6:117287353-117425942
Links
Phenotypes
GenCC
Source:
- male infertility with azoospermia or oligozoospermia due to single gene mutation (Moderate), mode of inheritance: AR
- breast cancer (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Lung adenocarcinoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ROS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 18 | ||||
missense | 104 | 15 | 12 | 132 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 4 | 6 | |||
non coding | 6 | |||||
Total | 1 | 2 | 106 | 26 | 23 |
Highest pathogenic variant AF is 0.000178
Variants in ROS1
This is a list of pathogenic ClinVar variants found in the ROS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-117288506-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
6-117288515-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
6-117288551-G-C | ROS1-related disorder | Likely benign (Sep 08, 2022) | ||
6-117288553-T-C | Benign (May 03, 2018) | |||
6-117288576-T-G | not specified | Uncertain significance (Aug 02, 2021) | ||
6-117288584-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
6-117288766-T-C | not specified | Uncertain significance (Apr 25, 2023) | ||
6-117288789-A-C | not specified | Uncertain significance (Feb 12, 2024) | ||
6-117288800-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
6-117301013-C-T | not specified | Uncertain significance (Jan 30, 2021) | ||
6-117301048-T-A | not specified | Uncertain significance (Sep 28, 2022) | ||
6-117301068-G-T | Likely benign (Nov 01, 2023) | |||
6-117301093-C-A | not specified | Uncertain significance (Aug 04, 2021) | ||
6-117308875-G-C | not specified | Uncertain significance (Dec 18, 2023) | ||
6-117310128-A-G | Likely benign (May 01, 2022) | |||
6-117310138-C-T | Conflicting classifications of pathogenicity (Jul 01, 2023) | |||
6-117310199-C-A | not specified | Uncertain significance (Dec 08, 2023) | ||
6-117310251-G-A | Likely benign (May 31, 2018) | |||
6-117310261-C-T | not specified | Uncertain significance (May 03, 2023) | ||
6-117311039-G-A | Neoplasm | - (-) | ||
6-117311093-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
6-117317154-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
6-117317179-G-T | not specified | Uncertain significance (Dec 13, 2023) | ||
6-117317181-C-T | Lung sarcomatoid carcinoma | Uncertain significance (-) | ||
6-117317184-C-T | Lung adenocarcinoma | Pathogenic/Likely pathogenic (Dec 26, 2014) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ROS1 | protein_coding | protein_coding | ENST00000368508 | 43 | 137556 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.62e-72 | 1.47e-10 | 125158 | 2 | 588 | 125748 | 0.00235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.501 | 1243 | 1.19e+3 | 1.04 | 0.0000585 | 15335 |
Missense in Polyphen | 357 | 353.45 | 1.01 | 4627 | ||
Synonymous | -1.93 | 478 | 427 | 1.12 | 0.0000212 | 4463 |
Loss of Function | 0.455 | 113 | 118 | 0.955 | 0.00000566 | 1490 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00634 | 0.00633 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00127 | 0.00125 |
Finnish | 0.00117 | 0.00116 |
European (Non-Finnish) | 0.00231 | 0.00230 |
Middle Eastern | 0.00127 | 0.00125 |
South Asian | 0.00420 | 0.00409 |
Other | 0.00247 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2. {ECO:0000269|PubMed:11094073, ECO:0000269|PubMed:16885344}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ROS1 is found in a glioblastoma multiforme sample. An intra-chromosomal deletion del(6)(q21q21) is responsible for the formation of GOPC-ROS1 chimeric protein which is localized to the Golgi and has a constitutive receptor tyrosine kinase activity. A SLC34A2-ROS1 chimeric protein produced in non-small cell lung cancer cells also retains a constitutive kinase activity. A third type of chimeric protein CD74-ROS1 was also identified in those cells. {ECO:0000269|PubMed:12661006}.;
- Pathway
- Spinal Cord Injury;NAD metabolism, sirtuins and aging
(Consensus)
Recessive Scores
- pRec
- 0.247
Intolerance Scores
- loftool
- 0.134
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.41
Haploinsufficiency Scores
- pHI
- 0.602
- hipred
- N
- hipred_score
- 0.325
- ghis
- 0.371
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.603
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ros1
- Phenotype
- reproductive system phenotype; cellular phenotype;
Gene ontology
- Biological process
- regulation of cell growth;columnar/cuboidal epithelial cell development;protein phosphorylation;transmembrane receptor protein tyrosine kinase signaling pathway;spermatogenesis;cell population proliferation;negative regulation of gene expression;regulation of phosphate transport;signal transduction by protein phosphorylation;cell differentiation;regulation of TOR signaling;peptidyl-tyrosine autophosphorylation;regulation of ERK1 and ERK2 cascade
- Cellular component
- integral component of plasma membrane;cell surface;membrane;receptor complex;perinuclear region of cytoplasm
- Molecular function
- protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;protein binding;ATP binding;protein phosphatase binding